Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial

Nombre investigadores: Yiming Mu, Xiaolei Bao, Freddy G Eliaschewitz, Morten Rix Hansen, Bom Taeck Kim, Anna Koroleva, Ronald C W Ma, Tao Yang, Ning Zu, Ming Liu; STEP 7 Study Group